Literature DB >> 15118523

Plasma protein C levels in patients with acute lung injury: prognostic significance.

Michael A Matthay1, Lorraine B Ware.   

Abstract

Decreased circulating protein C is a marker of a prothrombotic state that has been associated with poor clinical outcomes in sepsis. However, protein C has not been measured in patients with acute lung injury and acute respiratory distress syndrome (ALI/ARDS). In this study, we measured circulating and intra-alveolar concentrations of protein C in 45 patients with ALI/ARDS from septic and nonseptic causes. Plasma protein C levels were lower in ALI/ARDS compared with normal controls. Lower levels of plasma protein C were associated with worse clinical outcomes, including death, fewer ventilator-free days, and more nonpulmonary organ failures, even when only patients without sepsis were analyzed. In summary, the protein C system is markedly disrupted in patients with ALI/ARDS from both septic and nonseptic causes. The protein C system may be a therapeutic target in patients with ALI/ARDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118523     DOI: 10.1097/01.ccm.0000126121.56990.d3

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Feng Chen; Ednan K Bajwa; Peter F Clardy; Diana C Gallagher; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

2.  Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.

Authors:  Anil Sapru; Carolyn S Calfee; Kathleen D Liu; Kirsten Kangelaris; Helen Hansen; Ludmila Pawlikowska; Lorraine B Ware; Mustafa F Alkhouli; Jason Abbott; Jason Abbot; Michael A Matthay
Journal:  Intensive Care Med       Date:  2015-02-03       Impact factor: 17.440

3.  Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation.

Authors:  Heidi R Flori; Lorraine B Ware; Meredith Milet; Michael A Matthay
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

Review 4.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

5.  Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.

Authors:  Jason D Christie; Nancy Robinson; Lorraine B Ware; Michael Plotnick; Joao De Andrade; Vibha Lama; Aaron Milstone; Jonathan Orens; Ann Weinacker; Ejigayehu Demissie; Scarlett Bellamy; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

Review 6.  Biomarkers in pediatric acute respiratory distress syndrome.

Authors:  Erin F Carlton; Heidi R Flori
Journal:  Ann Transl Med       Date:  2019-10

7.  Discovery of the gene signature for acute lung injury in patients with sepsis.

Authors:  Judie A Howrylak; Tamas Dolinay; Lorrie Lucht; Zhaoxi Wang; David C Christiani; Jigme M Sethi; Eric P Xing; Michael P Donahoe; Augustine M K Choi
Journal:  Physiol Genomics       Date:  2009-01-27       Impact factor: 3.107

8.  Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome.

Authors:  Diana C Gallagher; Samir M Parikh; Konstantin Balonov; Andrew Miller; Shiva Gautam; Daniel Talmor; Vikas P Sukhatme
Journal:  Shock       Date:  2008-06       Impact factor: 3.454

9.  Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients.

Authors:  John H Peters; Mark N Grote; Nancy E Lane; Richard J Maunder
Journal:  Biomark Insights       Date:  2011-05-29

10.  Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury.

Authors:  Daryl Jon Kor; Daniel S Talmor; Valerie M Banner-Goodspeed; Rickey E Carter; Richard Hinds; Pauline K Park; Ognjen Gajic; Michelle N Gong
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.